Yesterday, the argument was that Labour is betting heavily on the NHS. Today, the case looks larger and considerably more positive. Health is becoming one of the few areas where the government can plausibly deliver an economic, social and political dividend at the same time.

There are not many easy wins available to a British prime minister. Growth is difficult, household finances remain tight, housing takes years to fix and tax is painful almost whichever way the government turns. Healthcare is different because, while it is difficult, expensive and unforgiving, it is also visible.

People know whether they can see a GP. They know whether their mother has finally had her operation. They know whether a cancer referral is moving. They know when their local hospital begins to feel better. That was the central argument yesterday: Labour needs something voters can actually experience before the next election.

There is now a bigger argument emerging. Health is becoming economic policy.

For years Whitehall has separated health, welfare, skills, productivity and economic growth. That distinction becomes increasingly artificial when poor health keeps people away from work or prevents them participating fully in the economy.

A hip replacement can be healthcare and employment policy. Faster mental-health treatment can be healthcare and skills policy. Earlier diagnosis can be healthcare and productivity policy.

Seen through that lens, the NHS starts to look rather different. It is no longer simply an enormous expenditure line that the Treasury has to contain. A high-performing health service can become part of the productive infrastructure of the country.

That is an important change in the politics of NHS funding.

The Spending Review has already provided for NHS day-to-day spending to rise by £29 billion in real terms between 2023-24 and 2028-29, reaching £226 billion by 2028-29. That is a significant commitment at a time when almost every part of government is competing for scarce money.

If health increasingly becomes connected to growth, employment and political confidence, the argument for protecting that investment becomes stronger.

But there is an equally important other half to the bargain.

More money will mean less tolerance for poor performance.

The NHS is already being asked to deliver 2 per cent annual productivity growth, more than three times its historic average of around 0.6 per cent. NHS England estimates that achieving the productivity requirement over the Spending Review period would unlock around £17 billion of savings.

That is not a small operational target. It represents a fundamental change in the relationship between funding and performance.

For NHS executive teams, the message is becoming clearer: the era in which additional funding could principally be absorbed by additional activity, workforce and cost is disappearing. Future investment will increasingly come with an expectation that trusts produce materially more from the assets, technology, workforce and estate they already have.

The pressure on waiting lists will intensify too. NHS England’s current planning framework expects the national waiting list to fall during 2026/27 and expects reductions across trusts, alongside improved referral-to-treatment performance.

That matters because waiting lists remain the political measure most people understand.

The NHS can publish sophisticated productivity metrics, financial positions and transformation programmes, but the patient asks a simpler question: when will I be treated?

Yesterday’s article made precisely that distinction. Statistical improvement becomes politically important only when patients actually experience it.

This is why the next few years could feel very different inside NHS boardrooms.

More money may be available, and politically health may become increasingly protected. But that does not mean the financial environment will become easier. In some respects it could become tougher.

Every pound will increasingly need a visible return.

More elective funding will need to mean more elective activity and shorter waits. Digital investment will need to produce measurable productivity. Capital will need to remove bottlenecks rather than simply modernise buildings. Workforce investment will need to translate into capacity. Prevention will increasingly be judged against whether it reduces future demand.

The government’s 10 Year Health Plan already points towards three fundamental shifts: hospital to community, analogue to digital and sickness to prevention.

Those phrases now need to move from policy language into operational reality.

That means executive teams will face much harder questions.

How much activity are we producing for every pound spent?

Why does one trust perform materially better than another with similar resources?

How much clinical time is technology actually releasing?

Which outpatient appointments no longer need to happen?

Which patients can safely be managed outside the hospital?

How quickly are innovations moving from pilot to routine care?

And perhaps most importantly: what changed for the patient?

This is not necessarily bad news for NHS leaders. Quite the opposite.

For perhaps the first time in years, there is the potential for a relatively coherent political settlement around health: sustained investment, greater technological ambition, more capital and stronger political sponsorship, but accompanied by a much clearer expectation of delivery.

Britain also possesses an extraordinary advantage in making that work. The country has leading universities, globally significant medical research, a sophisticated life-sciences industry and an NHS with a scale of patients, clinicians and data that few other health systems can replicate.

If those assets can finally be connected properly, healthcare becomes part of industrial strategy too.

The NHS can become a place in which new medicines are studied, AI is deployed, diagnostics are evaluated and advanced therapies reach patients more quickly. That can attract investment while simultaneously improving outcomes.

Britain’s historic weakness has rarely been invention. It has been deployment.

Fixing that gap could become one of the defining NHS reforms of the decade.

There is a political precedent. Labour’s relationship with the NHS begins with Attlee and Bevan, but Tony Blair demonstrated the modern electoral lesson. Investment combined with relentless attention to waiting times can produce improvements that voters recognise.

Blair understood something that remains true today: people do not experience government through a Treasury spreadsheet. They experience it when something important in their lives works. Yesterday’s article drew that line between Labour’s history and the opportunity facing the present government.

That is why health could become central to the next election.

Housing will matter. Tax will matter. Household affordability will matter enormously. But all are extraordinarily difficult to transform quickly.

The NHS offers more immediate levers. The government can increase diagnostics, improve theatre utilisation, redesign pathways, expand research, adopt technology and move more care into communities. Most importantly, it can measure whether people are being treated faster.

The electoral proposition could therefore become remarkably simple.

Are you waiting less? Can you get an appointment? Is your local NHS working better?

Those questions travel considerably further than most government strategies ever will.

And this is where the implications for NHS executive teams become profound.

If the health service becomes one of the government’s principal economic and political projects, performance will cease to be merely an NHS management concern. It becomes a Downing Street concern.

Trusts that deliver will have an increasingly powerful case for investment, autonomy and expansion. Organisations that repeatedly fail to convert resources into activity and outcomes should expect much greater scrutiny.

The NHS Oversight Framework for 2026/27 already points towards stronger accountability for organisational performance, while the financial framework requires trusts and ICBs to plan within explicit financial limits over multiple years.

The direction is unmistakable.

The NHS may get more political attention and more investment.

It will also be expected to earn them.

That should be welcomed.

Because the optimistic interpretation of the government’s NHS strategy is not that Britain is pouring ever more money into an unreformable service. It is that health is finally being recognised as an investment in people, productivity, science and national prosperity.

If waiting lists continue falling, productivity rises, innovation moves faster and people spend more of their lives healthy enough to work and participate, Labour will have something unusually powerful to take into the next election.

Not another promise about the NHS.

Evidence that it works.

Yesterday, the argument was that Labour was betting the farm on health.

Perhaps the better way to see it is this: the government may have identified one of Britain’s most valuable assets.

Now the NHS will be expected to prove what that asset is worth.